MS clinical trial

“Norwegian healthtech company, Otivio has announced that it has extended an exploratory clinical trial with Neuro-SysMed to confirm the potential of its non-invasive FlowOx medical device to alleviate multiple sclerosis symptoms.”

After Otivio came across a significant discovery for a potential new application for their device FlowOxTM 2.0, they have decided to extend their exploratory clinical trial to analyze and understand the functionality of the device for patients with Multiple Sclerosis (pwMS).